RxDoctor Payments DataLook up a doctor →

Tina Withrow

Family · North Charleston, SCNPI 1063928521

Payments from drug & device makers

$19,182in general payments, 2019–2025

Across 679 payments — averaging $28.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Novartis$1K
  • AstraZeneca$1K
  • Merck$949
  • Bristol Myers Squibb$835
  • E.r. Squibb & Sons, L.L.C.$799
  • plus $11K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen28$2,979
Novartis53$1,437
AstraZeneca(2 entities)57$1,337
Merck39$949
Bristol Myers Squibb43$835
E.r. Squibb & Sons, L.L.C.42$799
Lilly USA, LLC27$705
Johnson & Johnson27$670
Genentech USA, Inc.27$614
Sanofi16$595
Daiichi Sankyo Inc.16$575
Takeda Pharmaceuticals U.S.A., Inc.20$540
AbbVie17$521
Incyte Corporation16$488
Gilead(2 entities)20$464
Pfizer24$443
Novocure Inc.4$372
GSK18$369
Jazz Pharmaceuticals Inc.14$291
Taiho Oncology, Inc.14$287
Regeneron Healthcare Solutions, Inc.11$261
Seagen Inc.10$234
Rigel Pharmaceuticals, Inc.5$225
Sanofi-aventis U.S. LLC2$200
Adaptive Biotechnologies Corporation8$182
Eisai Inc.8$165
AVEO Pharmaceuticals, Inc.6$161
Bayer6$146
Epizyme, Inc.2$140
Pharmacyclics LLC, An Abbvie Company7$134
Sobi, Inc5$132
Beigene USA, Inc.5$119
Boehringer Ingelheim5$114
Deciphera Pharmaceuticals Inc.5$113
TG Therapeutics, Inc.1$107
Stemline Therapeutics Inc.4$103
Puma Biotechnology, Inc.5$97
Karyopharm Therapeutics Inc.4$97
Servier Pharmaceuticals LLC4$92
ADC Therapeutics America, Inc.5$92
G1 Therapeutics, Inc.4$84
Beone Medicines USA, Inc.4$73
Acrotech Biopharma Inc.3$68
Array Biopharma Inc3$60
Iovance Biotherapeutics, Inc.2$56
Recordati_rare_diseases_inc.2$55
CTI Biopharma Corp.3$55
EMD Serono, Inc.3$54
Morphosys, US Inc.3$50
Geron Corporation2$49
Genmab U.S., Inc.2$48
Astellas Pharma US Inc3$47
Myovant Sciences Inc.2$39
Accord Healthcare, Inc.1$33
Tersera Therapeutics LLC2$32
Fennec Pharmaceuticals, Inc.1$24
Pharmaessentia USA Corporation1$24
Blue Earth Diagnostics1$20
Syndax Pharmaceuticals, Inc.1$19
Mirati Therapeutics, Inc.1$19

How this compares

$19,182 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$79,079
Medicare patients
370
Services billed
1,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →